Retinal Vein Occlusion

The second most common retinal vascular disease after diabetic retinopathy. A blocked retinal vein can cause bleeding, fluid leakage, and vision loss—but timely diagnosis and modern therapy can protect and often restore sight.

At a Glance

Retinal vein occlusion (RVO) occurs when a vein draining the retina becomes blocked, causing blood and fluid to leak into the surrounding tissue. It is the second most common retinal vascular disease after diabetic retinopathy. RVO usually affects one eye and develops suddenly and without pain. The underlying risk factors are largely cardiovascular, making systemic health management essential.

Key Facts

2nd most common retinal vascular disease Usually one eye only Linked to cardiovascular health

Types

●BRVO — Branch RVO: a tributary vein is blocked, affecting a wedge of the retina. Better prognosis.
●CRVO — Central RVO: the main retinal vein is blocked, causing diffuse hemorrhages. More severe; risk of neovascular complications.

Common Symptoms

•Sudden painless blurring or vision loss in one eye
•Floaters (dark spots from blood in vitreous)
•Shadow or darkening in one area of the visual field
•Distorted or wavy central vision (if macula is swollen)

Risk Factors

•High blood pressure (most important modifiable risk)
•Diabetes, high cholesterol, atherosclerosis
•Glaucoma (elevated eye pressure)
•Blood clotting disorders; age 50+

How It's Diagnosed

Dilated eye exam reveals flame-shaped hemorrhages and optic disc swelling. OCT measures macular edema (the most common cause of vision loss). Fluorescein angiography maps vessel blockage and areas of ischemia.

Treatment Options

Anti-VEGF injections (first-line for macular edema in both BRVO and CRVO). Steroid implants for persistent edema. PRP laser for ischemic CRVO to reduce risk of neovascular glaucoma. Systemic management of blood pressure and cardiovascular risk is essential.

⚠ Seek Care Promptly If You Notice

•Sudden vision loss or blurring in one eye
•A shadow covering part of your visual field
•New floaters or flashes in one eye
•Any sudden, painless change in vision

Condition Image

Retinal vascular anatomy illustration area

Key Takeaway

Retinal vein occlusion is the second most common retinal vascular disease after diabetic retinopathy. Prompt evaluation and treatment can significantly improve visual outcomes.

What is Retinal Vein Occlusion?

Retinal vein occlusion (RVO) occurs when a vein that drains blood from the retina becomes obstructed. Because the blockage prevents normal blood flow, pressure builds behind the obstruction, causing blood and fluid to leak into the surrounding retinal tissue. This leads to retinal hemorrhages, swelling, and reduced oxygen delivery to the light-sensing cells. In medical literature, the condition is sometimes referred to as venous stasis retinopathy or hemorrhagic retinopathy.

The retina depends on a finely balanced network of arteries and veins. When a vein is compromised, fragile capillaries can rupture, and the macula—the central area of the retina responsible for sharp, detailed vision—may swell from accumulated fluid. Without appropriate treatment, RVO can result in permanent damage and irreversible vision loss.

Although RVO usually affects only one eye, the underlying health conditions that contribute to it often affect the entire body. For this reason, a diagnosis of RVO frequently prompts a broader evaluation of cardiovascular and metabolic health.

Types of Retinal Vein Occlusion

RVO is classified by the location of the blocked vein. Understanding whether the blockage is in a smaller branch or the main central trunk helps determine the severity of vision loss and guides treatment decisions.

BRVO

Branch Retinal Vein Occlusion

In a branch retinal vein occlusion, a smaller tributary vein becomes blocked. Because the obstruction is localized, it typically affects only a wedge-shaped section of the retina. Vision loss is often confined to one portion of the visual field, and the overall prognosis is generally more favorable than with central involvement.

●Represents the majority of RVO cases
●Often involves the superior temporal vessels
●May cause sectoral hemorrhages and localized edema

CRVO

Central Retinal Vein Occlusion

In a central retinal vein occlusion, the main retinal vein is blocked at or near the optic nerve. Blood cannot drain from any part of the retina, leading to diffuse hemorrhages, widespread swelling, and more substantial vision impairment. CRVO carries a higher risk of serious complications and is further categorized by blood flow status.

●Less common than BRVO but more visually threatening
●Divided into non-ischemic and ischemic forms
●Higher risk of neovascular complications

Ischemic vs. Non-Ischemic CRVO

When CRVO is diagnosed, your retina specialist will determine how severely blood flow has been disrupted. This distinction is critical because it strongly influences prognosis and the risk of complications.

Non-Ischemic CRVO

The milder form, in which retinal blood flow is partially preserved. Patients may experience moderate blurring or mild vision loss, and some degree of spontaneous improvement is possible. However, macular edema frequently develops and may still require treatment to optimize vision.

●Better visual prognosis overall
●Lower risk of abnormal new vessel growth

Ischemic CRVO

The more severe form, characterized by extensive poor blood flow (ischemia) across large areas of the retina. Vision loss is typically profound, and the risk of developing neovascularization—abnormal, fragile blood vessels that can bleed and raise eye pressure—is substantially higher.

●Poorer visual prognosis
●Requires close monitoring for neovascular glaucoma

Symptoms

Retinal vein occlusion usually develops suddenly and without pain. Because it most often affects just one eye, many people do not notice symptoms until they cover the unaffected eye. In BRVO, symptoms may be subtle or absent if the blocked vessel does not involve the macula. In CRVO, vision changes are usually more obvious.

Sudden painless vision loss or blurring

May range from mild haziness to severe, widespread blur involving the entire central field
Floaters

Dark spots, strands, or cobweb-like shapes caused by small amounts of blood leaking into the vitreous gel
Dark area or shadow in vision

Particularly noticeable in one quadrant with branch occlusions
Decreased color perception

Colors may appear washed out, dull, or less vivid than in the unaffected eye

Risk Factors

Retinal vein occlusion shares many risk factors with stroke, heart disease, and other circulatory disorders. Identifying and controlling these conditions is essential not only for treating the affected eye, but also for reducing the chance of recurrence in the fellow eye.

Age Over 50

The likelihood of RVO rises substantially after age 50 and continues to increase with advancing age as blood vessels become less elastic.

High Blood Pressure

Hypertension is the leading systemic risk factor. Chronic elevation damages and thickens vessel walls, predisposing them to clot formation.

Diabetes

Diabetes weakens blood vessels throughout the body. Diabetic retinopathy and RVO can coexist, compounding the risk of vision loss.

Glaucoma

Elevated pressure inside the eye can compress the central retinal vein as it exits the optic nerve, increasing the risk of CRVO.

Blood Disorders

Conditions that thicken the blood or promote clotting—such as polycythemia, hyperviscosity syndromes, or inherited thrombophilias—can predispose to venous occlusion.

Cardiovascular Disease

Atherosclerosis, high cholesterol, and a history of stroke or heart disease are associated with an increased risk of RVO.

Complications

The primary dangers of RVO arise from the leakage and poor circulation that follow a vein blockage. Two of the most significant complications are macular edema and neovascularization. Both can threaten central vision and may require prompt intervention.

Macular Edema

When fluid from leaking blood vessels accumulates in the macula, the central retina swells and thickens. This is the most common reason for vision loss in both BRVO and CRVO. The swelling distorts the precise architecture of the retina needed for reading, driving, and recognizing faces. Macular edema can fluctuate over time and often requires ongoing therapy to keep it under control.

Neovascularization

In response to inadequate blood flow, the retina may release signals that trigger the growth of fragile, abnormal new blood vessels. These vessels can bleed into the vitreous, causing sudden showers of floaters or severe vision loss. They can also grow on the iris and drainage structures of the eye, leading to neovascular glaucoma—a painful form of elevated eye pressure that can further damage the optic nerve. Pan-retinal laser photocoagulation is often used to regress these vessels and reduce the risk of catastrophic bleeding.

Other Potential Complications

●Vitreous hemorrhage from ruptured new vessels
●Retinal ischemia and permanent tissue damage
●Retinal detachment (rare, secondary to scar tissue)
●Chronic macular changes causing persistent distortion

Diagnosis

Accurate diagnosis guides every aspect of RVO management. Your retina specialist will combine a careful clinical examination with advanced imaging to confirm the diagnosis, classify the type and severity, detect macular edema, and identify areas of poor circulation.

Dilated Eye Exam

After dilating the pupil, the physician examines the retina with a specialized lens. The pattern, location, and extent of retinal hemorrhages help distinguish BRVO from CRVO and reveal signs of chronic damage such as cotton-wool spots or optic disc swelling.

Optical Coherence Tomography (OCT)

OCT uses light waves to capture high-resolution, cross-sectional images of the retina. It is the cornerstone for detecting and monitoring macular edema, precisely measuring retinal thickness, identifying subretinal fluid, and tracking how well the retina responds to treatment over time.

Essential for Monitoring

Fluorescein Angiography (FA)

A fluorescent dye is injected into a vein in the arm, and rapid photographs are taken as the dye circulates through the retinal vessels. FA highlights areas of leakage, identifies zones of poor perfusion (ischemia), and reveals abnormal new vessel growth. These findings are critical for deciding whether laser therapy is needed.

Additional Evaluations

●Visual acuity testing to measure the degree of vision loss
●Intraocular pressure measurement to assess glaucoma risk
●Systemic workup including blood pressure, glucose, and lipids
●Assessment of the fellow eye for early signs of disease

Treatment Options

There is currently no way to directly reopen the blocked vein. Instead, treatment targets the complications of RVO—principally macular edema and neovascularization—with the goal of stabilizing vision and, in many cases, achieving meaningful improvement.

Anti-VEGF Injections

Medications such as aflibercept (Eylea), ranibizumab (Lucentis), and bevacizumab (Avastin) are considered first-line therapy for most patients with macular edema due to RVO. These drugs inhibit vascular endothelial growth factor, a protein that makes vessels leaky. By blocking VEGF, the medications reduce swelling and often improve vision. Injections are typically administered monthly at the outset and later spaced according to OCT findings.

First-Line Treatment

Steroid Implants

Sustained-release corticosteroid implants, including dexamethasone (Ozurdex) and fluocinolone acetonide (Yutiq), offer an effective alternative or adjunct to anti-VEGF therapy. They are particularly useful for patients who have had cataract surgery or who do not respond adequately to anti-VEGF agents. Because steroids can raise eye pressure and accelerate cataract formation, patients receiving implants require careful monitoring.

Alternative / Adjunct

Laser Therapy

Laser photocoagulation remains an important tool in specific scenarios. Focal or grid laser may be applied to areas of leakage in BRVO-related macular edema. Pan-retinal photocoagulation (PRP) is used when neovascularization develops—most often in ischemic CRVO—to destroy oxygen-starved peripheral retina, thereby reducing the signals that drive abnormal vessel growth and lowering the risk of vitreous hemorrhage and neovascular glaucoma.

Targeted Laser

Managing underlying health conditions is essential. Controlling blood pressure, blood sugar, and cholesterol not only supports eye health but also reduces the risk of RVO occurring in the fellow eye. Treatment plans are highly individualized and adjusted based on OCT measurements, visual acuity, angiography, and your overall medical status.

Prognosis

The outlook after a retinal vein occlusion varies widely. Outcomes depend on the type of occlusion, the severity of macular edema, the degree of retinal ischemia, baseline visual acuity, and how quickly treatment is initiated. Modern therapies have transformed the prognosis for many patients, but vision does not always return to normal.

BRVO: Generally carries a better prognosis than CRVO. When the macula is not involved, some patients retain excellent vision. If macular edema develops, treatment often yields substantial improvement, and many eyes achieve functional reading or driving vision.
Non-ischemic CRVO: Tends to have a more favorable course than the ischemic form. Some individuals experience partial spontaneous recovery, though persistent macular edema frequently necessitates therapy to maximize vision.
Ischemic CRVO: Associated with the most guarded prognosis. Severe vision loss is common, and the eye remains at elevated risk for neovascularization and neovascular glaucoma even after treatment.

Factors That Improve Outcomes

Early diagnosis and prompt initiation of therapy
Higher baseline visual acuity before treatment
Younger age and otherwise good general health
Rigorous control of blood pressure, glucose, and lipids
Consistent follow-up with regular OCT monitoring

Protecting the fellow eye: Because systemic risk factors affect both eyes, regular examinations of the unaffected eye are important. The fellow eye carries a meaningful lifetime risk of developing a vein occlusion, making preventive medical management essential.

🔬 Clinical Trials

Active research for RVO — from ClinicalTrials.gov

▼

Clinical Trial Landscape

Research activity for Retinal Vein Occlusion — sourced live from ClinicalTrials.gov

Search all trials

Recruiting only

Loading trial data…

Frequently Asked Questions

Is retinal vein occlusion the same as a stroke in the eye?

RVO is sometimes described as an "eye stroke" because it involves a sudden vascular blockage. However, the term "stroke" typically refers to arterial events, whereas RVO is a venous blockage. The analogy is useful for understanding the abrupt onset and seriousness of the condition, but the mechanisms and treatments differ.

Can vision recover after a retinal vein occlusion?

Many patients do experience significant improvement with modern therapy, particularly anti-VEGF injections. Early treatment offers the best chance of recovery. That said, not all vision may be restored—especially in ischemic CRVO or when diagnosis is delayed—and some individuals have residual blurring or distortion.

How often will I need eye injections?

During the initial phase, injections are commonly given every four weeks. As the macular edema stabilizes and OCT scans show reduced swelling, your retina specialist may gradually lengthen the interval between treatments. Some patients achieve long-term stability with occasional maintenance doses, while others require more frequent therapy.

Can RVO happen in my other eye?

Yes. Because the systemic conditions that predispose to RVO—such as hypertension and diabetes—affect the entire body, the fellow eye is also at risk over time. Controlling these underlying health issues is the most effective way to lower the chance of a second event.

Will I need to see other doctors besides my retina specialist?

Often, yes. RVO is frequently a sign of broader vascular disease. Your retina specialist may recommend follow-up with your primary care physician, a cardiologist, or an endocrinologist to evaluate and manage high blood pressure, diabetes, cholesterol, and clotting disorders.

What happens if retinal vein occlusion is left untreated?

Without treatment, chronic macular edema can lead to permanent structural damage in the central retina. In ischemic forms, neovascularization may develop, causing vitreous hemorrhage or painful neovascular glaucoma. Early intervention greatly reduces the risk of these serious complications.

TrialFlow Patient Education

Patient Information

Date: _______________

Patient: _______________

Retinal Vein Occlusion (RVO)

What Is It?

Retinal vein occlusion occurs when a vein in the retina becomes blocked, causing blood and fluid to leak into the retina. This leads to vision loss. It is more common in older adults and those with high blood pressure, diabetes, or glaucoma.

Symptoms to Watch For

Sudden painless vision loss or blurring
Dark spots or floaters
Distorted vision
Vision loss may be in one section (BRVO) or entire central vision (CRVO)

Treatment

Anti-VEGF eye injections to reduce swelling
Steroid implants for persistent macular edema
Laser treatment to improve blood flow
Management of underlying conditions (blood pressure, diabetes, glaucoma)

⚠ Seek Immediate Help If:

Sudden vision loss or blurring
New floaters or flashes
Any sudden change in vision

Go to the emergency room or call your retina specialist immediately.

Follow-Up Instructions

You may need monthly injections initially, then less frequently as the condition stabilizes. Regular OCT scans monitor swelling. Controlling blood pressure and diabetes is essential to prevent recurrence in the other eye.

Doctor's Notes